New diabetes clinical trial: A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

Published on: September 18, 2024 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: HRS-7535 tablet; Drug: dapagliflozin tablet
Sponsors: Shandong Suncadia Medicine Co., Ltd.
Not yet recruiting
https://ift.tt/9QvlJdm